investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Nathanael Schiander Gray

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Eusebio Manchado-Robles

Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers

Trachea, bronchus and lung

Dennis Klinman

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides 

Trachea, bronchus and lung

Peter S Hammerman

Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers

Trachea, bronchus and lung

Raghu Kalluri

Targeting Pericytes in Cancer

Trachea, bronchus and lung

Roman Perez-Soler

Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy

Trachea, bronchus and lung

Peter Kent Jackson

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

Trachea, bronchus and lung

A. Mcgarry Houghton

IRS-1 Regulates Inflammatory Cell Recruitment in Lung Cancer

Trachea, bronchus and lung

Joseph R Testa

RIP1/3 Kinases as New Targets in Malignant Mesothelioma

Trachea, bronchus and lung

Pathology

Mark G. Kris

Targets for Therapy for Carcinomas of the Lung

Trachea, bronchus and lung